HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice

BACKGROUND: Hepatitis B virus (HBV) persistently infected about 250 million people worldwide, and a curative treatment remains an unmet medical need. Among many approaches to treat chronic hepatitis B (CHB), therapeutic vaccines have been developed for two decades, but none have yielded promising re...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Biomed Sci
Päätekijät: Horng, Jau-Hau, Lin, Wei-Hsiang, Wu, Chang-Ru, Lin, You-Yu, Wu, Li-Ling, Chen, Ding-Shinn, Chen, Pei-Jer
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2020
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7257178/
https://ncbi.nlm.nih.gov/pubmed/32466788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-020-00662-x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia